Platelet-rich plasma (PRP) is currently used in different medical fields. The interest in the application of PRP in dermatology has recently increased. It is being used in several different applications as in tissue regeneration, wound healing, scar revision, skin rejuvenating effects, and alopecia. PRP is a biological product defined as a portion of the plasma fraction of autologous blood with a platelet concentration above the baseline. It is obtained from the blood of patients collected before centrifugation. The knowledge of the biology, mechanism of action, and classification of the PRP should help clinicians better understand this new therapy and to easily sort and interpret the data available in the literature regarding PRP. In this review, we try to provide useful information for a better understanding of what should and should not be treated with PRP.

Keywords:
Platelet-rich plasma, Plasma, Autologous therapy, Biology, Mechanism of action
1.
Andia I, Abate M: Platelet rich plasma: underlying biology and clinical correlates. Regen Med 2013;8:645-658.
2.
Andia I: Platelet-rich plasma biology; in Alves R, Grimalt R (eds): Clinical Indications and Treatment Protocols with Platelet-Rich Plasma in Dermatology. Barcelona, Ediciones Mayo, 2016, pp 3-15.
3.
Conde Montero E, Fernández Santos ME, Suárez Fernández R: Platelet-rich plasma: applications in dermatology. Actas Dermosifiliogr 2015;106:104-111.
4.
Lynch MD, Bashir S: Applications of platelet-rich plasma in dermatology: a critical appraisal of the literature. J Dermatolog Treat 2016;27:285-289.
5.
Andia E, Rubio-Azpeitia J, Martin I, Abate M: Current concepts and translational uses of platelet rich plasma biotechnology; in Ekinci D (ed.): Biotechnology. InTech, 2015, DOI: 10.5772/59954. https://www.intechopen.com/books/biotechnology/current-concepts-and-translational-uses-of-platelet-rich-plasma-biotechnology.
6.
Li ZJ, Choi HI, Choi DK, Sohn KC, Im M, Seo YJ, Lee YH, et al: Autologous platelet-rich plasma: a potential therapeutic tool for promoting hair growth. Dermatol Surg 2012;38:1040-1046.
7.
Sommeling CE, Heyneman A, Hoeksema H, Verbelen J, Stillaert FB, Monstrey S: The use of platelet-rich plasma in plastic surgery: a systematic review. J Plast Reconstr Aesthet Surg 2013;66:301-311.
8.
Salazar-Álvarez AE, Riera-del-Moral LF, García-Arranz M, Alvarez-García J, Concepción-Rodriguez NA, Riera-de-Cubas L: Use of platelet-rich plasma in the healing of chronic ulcers of the lower extremity. Actas Dermosifiliogr 2014;105:597-604.
9.
Picard F, Hersant B, Bosc R, Meningaud JP: Should we use platelet-rich plasma as an adjunct therapy to treat “acute wounds”, “burns”, and “laser therapies”: a review and a proposal of a quality criteria checklist for further studies. Wound Repair Regen 2015;23:163-170.
10.
Cobos R, Aizpuru F, Parraza N, Anitua E, Orive G: Effectiveness and efficiency of platelet rich plasma in the treatment of diabetic ulcers. Curr Pharm Biotechnol 2015;16:630-634.
11.
Sclafani AP, Azzi J: Platelet preparations for use in facial rejuvenation and wound healing: a critical review of current literature. Aesthec Plast Surg 2015;39:495-505.
12.
Conde Montero E: PRP in wound healing; in Alves R, Grimalt R (eds): Clinical Indications and Treatment Protocols with Platelet-Rich Plasma in Dermatology. Barcelona, Ediciones Mayo, 2016, pp 59-72.
13.
Kim DH, Je YJ, Kim CD, Lee YH, Seo YJ, Lee JH, Lee Y: Can platelet-rich plasma be used for skin rejuvenation? Evaluation of effects of platelet-rich plasma on human dermal fibroblast. Ann Dermatol 2011;23:424-431.
14.
Sclafani AP, McCormick SA: Induction of dermal collagenesis, angiogenesis, and adipogenesis in human skin by injection of platelet-rich fibrin matrix. Arch Facial Plast Surg 2012;14:132-136.
15.
Lola Bou Camps: PRP in cosmetic dermatology; in Alves R, Grimalt R (eds): Clinical Indications and Treatment Protocols with Platelet-Rich Plasma in Dermatology. Barcelona, Ediciones Mayo, 2016, pp 45-57.
16.
Girão L: PRP and other applications in dermatology; in Alves R, Grimalt R (eds): Clinical Indications and Treatment Protocols with Platelet-Rich Plasma in Dermatology. Barcelona, Ediciones Mayo, 2016, pp 73-78.
17.
Giordano S, Romeo M, Lankinen P: Platelet-rich plasma for androgenetic alopecia: does it work? Evidence from meta analysis. J Cosmet Dermatol 2017, Epub ahead of print.
18.
Ayatollahi A, Hosseini H, Gholami J, Mirminachi B, Firooz F, Firooz A: Platelet rich plasma for treatment of non-scarring hair loss: systematic review of literature. J Dermatolog Treat 2017, Epub ahead of print.
19.
Theml H: Physiology and pathophysiology of blood cells; in Theml H, Diem H, Haferlach T (eds): Color Atlas of Hematology. Stuttgart, Thieme, 2004.
20.
Harmon K, Hanson R, Bowen J, Greenberg S, Magaziner E, Vandenbosch J, et al: Guidelines for the use of platelet rich plasma. https://www.scribd.com/document/159334949/206-ICMS-Guidelines-for-the-Use-of-Platelet-Rich-Plasma-Draftob-oasbonasdandbowndoww.
21.
Ferrando J, Fernández-Sartorio C, González de Cossío AC, Navarra E: Tratamiento de la alopecia androgenetica con factores de crecimiento plaquetario. Monografías Dermatología 2016;42:491-497.
22.
Alves R, Grimalt R: A randomized placebo-controlled, double-blind, half-head study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia. Dermatol Surg 2016;42:491-497.
23.
Wroblewski AP, Melia HJ, Wright VJ: Application of platelet-rich plasma to enhance tissue repair. Oper Tech Orthop 2010;20:98-105.
24.
Graziani F, Ivanovski S, Cei S, Ducci F, Tonetti M, Gabriele M: The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res 2006;17:212-219.
25.
Gupta AK, Carviel J: A mechanistic model of platelet-rich plasma treatment for androgenetic alopecia. Dermatol Surg 2016;42:1335-1339.
26.
Uebel CO, da Silva JB, Cantarelli D, Martins P: The role of platelet plasma growth factors in male pattern baldness surgery. Plast Reconstr Surg 2006;118:1458-1466.
27.
Takikawa M, Nakamura S, Nakamura S, Ishirara M, Kishimoto S, Sasaki K: Enhanced effect of platelet-rich plasma containing a new carrier on hair growth. Dermatol Surg 2011;37:1721-1729.
28.
Paus R: Do we need hair follicle stem cells, hair follicle neogenesis to cure common hair loss disorders? Hair Transplant Forum Int 2008;18:89-90.
29.
Lin WH, Xiang LJ, Shi HX, Zhang J, Jiang LP, Cai PT, et al. Fibroblast growth factors stimulate hair growth through β-catenin and Shh expression in C57BL/6 mice. Biomed Res Int 2015;2015:73017.
30.
Jain R, De-Eknamkul W: Potential targets in the discovery of new hair growth promoters for androgenic alopecia. Expert Opin Ther Targets 2014;18:787-806.
31.
Akiyama M, Smith LT, Holbrook KA: Growth factor and growth factor receptor localization in the hair follicle bulge and associated tissue in human fetus. J Invest Dermatol 1996;106:391-396.
32.
Myung PS, Takeo M, Ito M, Atit RP: Epithelial Wnt ligand secretion is required for adult hair follicle growth and regeneration. J Invest Dermatol 2013;133:31-41.
33.
Dhurat R, Sukesh M: Principles and methods of preparation of platelet-rich Plasma: a review and author's perspective. J Cutan Aesthet Surg 2014;7:189-197.
34.
Magalon J: Medical devices for the production of PRP: main aspects to be considered; in Alves R, Grimalt R (eds): Clinical Indications and Treatment Protocols with Platelet-Rich Plasma in Dermatology. Barcelona, Ediciones Mayo, 2016, pp 17-28.
35.
Arshdeep, Kumaran MS: Platelet-rich plasma in dermatology: boon or a bane? Indian J Dermatol Venereol Leprol 2014;80:5-14.
36.
Anitua E, Sánchez M, Orive G: The importance of understanding what is platelet-rich growth factor (PRGF) and what is not. J Shoulder Elbow Surg 2011;20:e23-e24.
37.
Dohan Ehrenfest DM, Sammartino G, Shibli JA, Wang HL, et al: Guidelines for the publication of articles related to platelet concentrates (platelet-rich plasma - PRP, or platelet-rich fibrin - PRF): the international classification of the POSEIDO. POSEIDO 2013;1:17-27.
38.
Dohan Ehrenfest DM, Rasmusson L, Albrektsson T: Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009;2:158-167.
39.
Dohan Ehrenfest DM, Bielecki T, Mishra A, Borzini P: In search of a consensus terminology in the field of platelet concentrates for surgical use: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), fibrin gel polymerization and leukocytes. Curr Pharm Biotechnol 2012;13:1131-1137.
40.
Mishra A, Harmon K, Woodall J, Vieira A: Sports medicine applications of platelet rich plasma. Curr Pharm Biotechnol 2012;13:1185-1195.
41.
Magalon J, Chateau AL, Bertrand B, Louis ML, Silvestre A, Giraudo L, et al: DEPA classification: a proposal for standardising PRP use and a retrospective application of available devices. BMJ Open Sport Exerc Med 2016;2:e000060.
42.
De Pascale MR, Sommese L, Casamassimi A, Napoli C: Platelet derivatives in regenerative medicine: an update. Transfus Med Rev 2015;29:52-61.
43.
Du Cros DL: Fibroblast growth factor and epidermal growth factor in hair development. J Invest Dermatol 1993;101(1 suppl):106S-113S.
44.
Takabayashi Y, Nambu M, Ishihara M, Kuwabara M, Fukuda K, Nakamura S, et al: Enhanced effect of fibroblast growth factor-2-containing dalteparin/protamine nanoparticles on hair growth. Clin Cosmet Investig Dermatol 2016;9:127-134.
45.
Shi HX, Lin C, Lin BB, Wang ZG, Zhang HY, Wu FZ, et al: The anti-scar effects of basic fibroblast growth factor on the wound repair in vitro and in vivo. PLoS One 2013;8:e59966.
46.
Eppley BL, Pietzak WS, Blanton M: Platelet-rich plasma: a review of biology and applications in plastic surgery. Plast Reconstr Surg 2006;118:147e-159e.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.